NCT04293549
An 8-week Follow-up to Evaluate the Renewal of Corneal Nerves Structure and Function in Patients With Neurotrophic Keratopathy Treated With Recombinant Human Nerve Growth Factor (rhNGF) Eyedrops Not Available Not Available completed NCT06412718
Validation of Human Drugs Target of Repurposed Drugs and Novel Therapies No drug interventions Not Available Not Available not_yet_recruiting NCT04604834
Autologous Platelet-rich Plasma (APRP) in the Treatment of Neurotrophic Keratopathy No drug interventions treatment Not Available recruiting NCT04957758
Phase 2 Clinical Trial to Evaluate OC-01 Nasal Spray in Subjects With Neurotrophic Keratopathy treatment 2 completed NCT02600429
Assessment of the Safety and Efficacy Study of RGN-259 Ophthalmic Solutions for Neurotrophic Keratopathy : SEER-1 No drug interventions treatment 3 terminated NCT05555589
Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2 treatment 3 recruiting NCT06411145
Open-label Trial to Evaluate Efficacy and Safety of rhNGF on Corneal Thickness Via AS-OCT in Neurotrophic Keratitis treatment 4 active_not_recruiting NCT03084861
A Clinical Trial to Asses Efficacy and Safety of Cord Blood Eye Drops in Neurotrophic Keratopathy No drug interventions treatment 1 / 2 terminated NCT06331910
Efficacy and Safety of Topical Insulin for Neurotrophic Corneal Ulcers treatment 4 not_yet_recruiting NCT04909450
Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects No drug interventions treatment 1 / 2 completed NCT05552261
DEFENDO Long Term Follow-up Study in Stage 1 NK Patients Not Available Not Available completed NCT06597422
A Study of STSP-0902 Ophthalmic Solution in Healthy Subjects No drug interventions treatment 1 not_yet_recruiting NCT05758753
QST for Corneal Nerve Function No drug interventions treatment Not Available enrolling_by_invitation NCT05927428
Assessment of the Initial Efficacy and Safety of BRM424 Ophthalmic Solutions in Patients With Neurotrophic Keratitis treatment 2 not_yet_recruiting NCT01756456
Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis. treatment 1 / 2 completed NCT05566717
An Investigator-Initiated Study to Assess the Association of Diabetic Retinopathy Severity Scale (DRSS) With Level of Decreased Corneal Sensitivity No drug interventions Not Available Not Available unknown_status NCT06364657
Differences in Corneal Structure and Function in Patients With Sjogrens vs. Non-Sjogrens Dry Eye No drug interventions Not Available Not Available recruiting NCT05321251
Topical Insulin Drops for the Treatment of Neurotrophic Keratopathy. treatment 2 / 3 withdrawn NCT02227147
Evaluation of Efficacy of 20 µg/ml rhNGF New Formulation (With Anti-oxidant) in Patients With Stage 2 and 3 NK treatment 2 completed NCT04573647
OCT Evaluation of Neurotrophic Ulcer Following Treatment With Oxervate Not Available Not Available recruiting NCT05809245
Corneal Neurotization as a Treatment for Neurotrophic Keratopathy No drug interventions treatment Not Available terminated NCT04627571
Corneal Nerves After Treatment With Cenegermin Not Available Not Available recruiting NCT04276558
REC 0/0559 Eye Drops for Treatment of Moderate and Severe Neurotrophic Keratitis in Adult Patients treatment 2 completed NCT04552730
Nerve Growth Factor for the Treatment of Cornea Disease Not Available Not Available completed NCT02707120
Efficacy and Safety of Plasma Rich in Growth Factors (PRGF-Endoret) Eye-drops in the Treatment of Neurotrophic Keratitis No drug interventions treatment 4 unknown_status NCT04485546
Study to Evaluate OXERVATE™ in Patients With Stage 1 Neurotrophic Keratitis treatment 4 completed NCT04820010
Topical Insulin - Utility and Results in Neurotrophic Keratopathy in Stages 2 and 3 Not Available Not Available completed NCT03037450
Miniinvasive Corneal Neurotization. A Pilot Study. No drug interventions treatment Not Available terminated